https://www.selleckchem.com/products/GDC-0449.html
A multivariable analysis confirmed that performance status, stage, and the SP142 assay were independent predictors of OS. In subgroup analysis, these results revealed more significant prognostic factors in ES than in limited-stage (LS). In patients with SCLC, especially those with ES, the expression of the SP142 assay is a significant independent prognostic factor. Although these results need to be further validated in larger cohorts, this information will benefit clinicians and patients in determining the immunotherapy for patients wi
Like
Comment
Share
